A review of perioperative treatment strategies with immunotherapy and tyrosine kinase inhibitors in resectable and stage IIIA-N2 non-small cell lung cancer

A review of perioperative treatment strategies with immunotherapy and tyrosine kinase inhibitors in resectable and stage IIIA-N2 non-small cell lung cancer

Stage IIIA-N2 non-small cell lung cancer (NSCLC) is a heterogeneous group with different potential therapeutic approaches. Treatment is typically multimodal with either surgical resection after neoadjuvant chemotherapy and/or radiation or concurrent chemotherapy and radiation if unresectable. Despit...

Full description

Bibliographic Details
Main Authors: Madeleine B. Hopson, Sawsan Rashdan
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Oncology
Subjects:
lung cancer
immunotherapy
tyrosine kinase inhibitors
adjuvant
neoadjuvant
early-stage
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1373388/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1373388/full

Similar Items